CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations
Sonar Soni Panigoro,
Samuel J. Haryono,
Prihantono Prihantono,
Dedy Hermansyah,
Sumadi Lukman Anwar,
Yohana Azhar,
Febriyanto Kurniawan,
Putu Anda Tusta Adiputra,
Kristanto Yuli Yarso,
Asdi Wihandono Asia-Pacific Journal of Clinical Oncology
· Wiley
· 2026-09-02
· DOI: 10.1111/ajco.70168
The publisher did not provide an abstract — full text is available via the link below.
Sonar Soni Panigoro, Samuel J. Haryono, Prihantono Prihantono, Dedy Hermansyah, Sumadi Lukman Anwar, Yohana Azhar et al. CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70168. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70168?af=R
Sonar Soni Panigoro, Samuel J. Haryono, Prihantono Prihantono, Dedy Hermansyah, Sumadi Lukman Anwar, Yohana Azhar, Febriyanto Kurniawan, Putu Anda Tusta Adiputra, Kristanto Yuli Yarso, & Asdi Wihandono (2026). CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70168
Sonar Soni Panigoro, et al. “CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70168.
@article{Panigoro2026,
title = {CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations},
author = {Panigoro, Sonar Soni and Haryono, Samuel J. and Prihantono, Prihantono and Hermansyah, Dedy and Anwar, Sumadi Lukman and Azhar, Yohana and Kurniawan, Febriyanto and Adiputra, Putu Anda Tusta and Yarso, Kristanto Yuli and Wihandono, Asdi},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70168},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70168?af=R}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment